Researchers have discovered that monocytes, a type of white blood cell, drive persistent and sustained inflammation that leads to lung…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Enrollment of adults at sites across the U.S. is continuing for a Phase 2a trial of AR-501 (gallium citrate),…
The incidence of colorectal cancer (CRC) in people with cystic fibrosis (CF) was five times higher than in those…
Newborn genetic screening panels for variants in the CFTR gene — mutations of which are the underlying cause of…
Trikafta (elexacaftor, tezacaftor, and ivacaftor) was found to successfully lessen the microbial load in the airways of people with…
A new study suggests that the use of anti-inflammatory medications to modulate immune signaling proteins in people with cystic…
Higher weight in children with cystic fibrosis (CF) at 1 year of age, and increasing weight gain from ages…
In children with cystic fibrosis (CF), chronic lung infection with methicillin-susceptible Staphylococcus aureus (MSSA) before age 4 was associated…
Adults with cystic fibrosis (CF) are willing to accept reductions in lung function and life expectancy as a trade-off…
Mothers who care for children with cystic fibrosis (CF) often experience depression, burnout, caregiver burden, and negative attitudes toward…